Bruschettini
Bruschettini is an Italian private pharmaceutical and medical-device company, founded in 1910 in Genova, that develops and manufactures respiratory, primary care, and ophthalmic pharmaceutical products for the Italian and adjacent European markets.
- Company typePrivate
- Founded1910
- HeadquartersGenova, Italy
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bruschettini does
Bruschettini is a privately held Italian pharmaceutical and medical-device manufacturer founded in 1910 and headquartered in Genova, Italy. According to the firmographic record, the company develops and manufactures products across three therapeutic categories — respiratory, primary care, and ophthalmic pharmaceuticals — alongside medical devices, an unusually diversified mix for a 110-year-old mid-cap Italian specialty manufacturer. With 101–250 employees, Bruschettini sits in the small-to-mid-cap tier of Italian pharmaceutical producers, a size class that is rare for a firm with this much operating history and that implies either a durable niche positioning or gradual scope-differentiation over the long corporate lifespan.
Bruschettini firmographics
Firmographics- Name
- Bruschettini
- Website
- https://bruschettini.com
- Company type
- Private
- Founded year
- 1910
- Headcount range
- 101–250 employees
- Short description
- Bruschettini is an Italian private pharmaceutical and medical-device company, founded in 1910 in Genova, that develops and manufactures respiratory, primary care, and ophthalmic pharmaceutical products for the Italian and adjacent European markets.
- Ownership category
- akta.pro rank
Bruschettini industry classification
Industry- Product category
- Pharmaceutical & Medical Device Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Surgical and Medical Instrument Manufacturing (339112), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Respiratory & Allergy Pharmaceuticals (HLAIAAAH)
- akta.pro secondary industries
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Bruschettini is headquartered
LocationHeadquarters
- HQ city
- Genova
- HQ country
- Italy
- HQ region
- Europe
Markets served
Bruschettini business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Bruschettini product offering
Product offeringCore offering
Bruschettini develops and manufactures pharmaceutical products in three therapeutic areas — respiratory, primary care, and ophthalmology — alongside a portfolio of medical devices. The company operates as a traditional pharmaceutical and medical-device producer headquartered in Genova, Italy, with a heritage dating to 1910. Its business centers on formulating, producing, and bringing to market finished drug products and physical medical devices for healthcare providers and patients.
Product overview
No product or service details are available from the provided source content. The website displays only a logo and loading state without any product descriptions, features, or named offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Respiratory pharmaceutical products
Companies that use Bruschettini
Customer profileIdeal customer profiles3 records
Bruschettini technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bruschettini competitors and assessment
Company assessmentDirect peers
- Chiesi Farmaceutici: Italian privately-held specialty pharma headquartered in Parma with a strong respiratory franchise and growing ophthalmology and rare disease presence — directly comparable to Bruschettini on therapeutic focus, Italian mid-sized private status, and respiratory leadership.
- Recordati: Milan-based specialty pharma with established operations across multiple European therapeutic areas including ophthalmology and primary care — comparable to Bruschettini in being an Italian, multi-therapeutic specialty pharma with international reach.
- Zambon: Privately-held Italian pharmaceutical group with respiratory and CNS specialty pharma operations — directly comparable to Bruschettini in scale, Italian private ownership, and respiratory therapeutic focus.
- Dompé: Italian biopharmaceutical company developing specialty therapeutics across ophthalmology and primary care — comparable to Bruschettini on therapeutic verticals, mid-sized private European specialty pharma profile, and ophthalmology positioning.
- Santen Pharmaceutical: Specialty pharma focused exclusively on ophthalmology with European commercial operations — directly comparable to Bruschettini's ophthalmic pharmaceutical business, both serving eye-care specialists with prescription therapeutics.
- Almirall: European specialty pharma headquartered in Spain with strong dermatology and respiratory franchises — comparable to Bruschettini on European mid-sized specialty pharma profile and respiratory therapeutic focus.
Broad incumbents
- Angelini Pharma: Privately-held Italian pharma group operating across primary care, specialty care, and consumer health — comparable to Bruschettini in Italian private ownership and primary-care pharmaceutical focus, though larger and more diversified.
- Bausch + Lomb: Global ophthalmology-focused pharmaceutical and medical device company — comparable to Bruschettini's ophthalmic pharmaceutical and medical device offerings, though operating at significantly larger scale and broader geographic reach.
- Menarini: Largest privately-held Italian pharmaceutical group with diversified portfolio spanning primary care, specialty, and diagnostics — comparable to Bruschettini on Italian private ownership and primary-care focus, but substantially larger and more internationally diversified.
Emerging players
- IBSA Institut Biochimique: Swiss-based specialty pharma with portfolio spanning ophthalmology, reproductive medicine, and primary care — comparable to Bruschettini on mid-sized European specialty pharma profile and ophthalmic pharmaceutical focus, though with a different geographic base.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Bruschettini financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bruschettini leadership team
Management profileNumber of profiles
Bruschettini funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bruschettini M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bruschettini
What does Bruschettini do?
Bruschettini develops and manufactures pharmaceutical products in three therapeutic areas — respiratory, primary care, and ophthalmology — alongside a portfolio of medical devices. The company operates as a traditional pharmaceutical and medical-device producer headquartered in Genova, Italy, with a heritage dating to 1910. Its business centers on formulating, producing, and bringing to market finished drug products and physical medical devices for healthcare providers and patients.
When was Bruschettini founded?
Bruschettini was founded in 1910. It employs 101 to 250 people.
Where is Bruschettini based?
Bruschettini is headquartered in Genova, Italy, in the Europe region.
Who are Bruschettini's main competitors?
Direct peers on record are Chiesi Farmaceutici, Recordati, Zambon, Dompé, Santen Pharmaceutical and Almirall. Broad incumbents are Angelini Pharma, Bausch + Lomb and Menarini. IBSA Institut Biochimique is listed as an emerging player.
Does Bruschettini have an API?
No public API is recorded for Bruschettini.
What industry is Bruschettini in?
Bruschettini's product category is Pharmaceutical & Medical Device Manufacturing. Its primary akta.pro industry code is HLAIAAAH, Respiratory & Allergy Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.